Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Explore the wash sale rule as it applies to dividend ETFs and strategies to avoid unnecessary tax complications.
12,423 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
If you want exposure to the biggest growth names in the U.S., two popular options are MGK and QQQ. This guide breaks ...
JPMorgan Nasdaq Equity Premium Income ETF appears to offer steady monthly income, but a closer look at its equity-lin...
Two popular tech ETFs, Vanguard VGT and iShares IYW, promise big growth but take different paths to get there. This g...
AI investing can take two paths: a targeted, actively managed approach with CHAT or a broad, low-cost tech track with...
A growing retirement strategy uses MLP ETFs to deliver about $34,000 a year from a $450,000 investment, while avoidin...
Starbucks could be on the cusp of rapid global growth, especially outside its home market. This guide explains what d...
Investors are eyeing income by selling covered calls on leveraged ETFs such as TQQQ, but the triple daily leverage ra...
A pipeline-focused ETF is drawing retirees with its steady monthly payouts, delivering roughly 7.8% annual yield and ...
An inherited IRA can be a powerful retirement tool, but mishandling it costs you. This guide reveals the biggest miss...
Six Republican senators warn Basel’s 1,250% risk weight could lock banks out of Bitcoin, a hurdle as Congress debates...
The U.S. Department of Housing and Urban Development announced a proposed rule to let upper-level sections of multi-s...